Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.72 USD | -2.11% | +5.26% | +24.59% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.59% | 320M | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+3.09% | 22.82B | |
-11.04% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- Atea Pharmaceuticals : Morgan Stanley Adjusts Atea Pharmaceuticals' Price Target to $82 from $49, Keeps Overweight Rating